Sign In
Buy PHG
$25.35
-0.0800 (-0.315%)
At Close: Jun 03, 2026
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "India Mixer Grinder Market 2023-2029 Segmentation, Growth, Companies, Revenue, Trends, Share, Outlook, Forecast, Industry, Analysis, Value & Size: Market
Philips (PHG) Boosts Precision Diagnosis With AI Platform
12:41pm, Wednesday, 05'th Jun 2024
Philips (PHG) boosts its Precision Diagnosis portfolio with an AI-powered ultrasound platform, strengthening its Diagnosis & Treatment segment.
May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: P
Philips (PHG) Boosts Medical Imaging Footprint With New Move
12:26pm, Wednesday, 29'th May 2024
Philips (PHG) expands its international footprint with the wide availability of VeriSight Pro 3D to several Hong Kong hospitals, strengthening its Diagnosis & Treatment segment.
Here's Why Royal Philips (PHG) is a Strong Value Stock
10:45am, Friday, 24'th May 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Philips successfully prices offering of Notes for EUR 700 million to be used for repayment of existing debt
04:31pm, Thursday, 23'rd May 2024
May 23, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixe
Philips (PHG) Strengthens Patient Monitoring Services in Spain
02:10pm, Thursday, 23'rd May 2024
Philips (PHG) announces the wide availability of its ambulatory cardiac monitoring service in Spain, boosting its patient monitoring solutions portfolio.
Martingale Risk – Philips Shareholders Group Action to be Filed in the Netherlands
04:06am, Thursday, 23'rd May 2024
LONDON--(BUSINESS WIRE)--Martingale Risk, a specialist in global securities loss recovery, is originating a group action in the Netherlands against Philips on behalf of institutional investors, togeth
Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients
04:00am, Wednesday, 22'nd May 2024
May 22, 2024 Philips wearable ePatch and AI analytics platform help detect potentially life-threatening irregular heartbeats The solution helps University Hospital Vall d'Hebron achieve reduced averag
Philips Foundation 2023 Annual Report: unlocking quality medical services for over 28 million people in underserved communities
09:00am, Tuesday, 21'st May 2024
May 21, 2024 Progress towards Philips Foundation's 2030 target of 100 million lives improved in underserved communities each year 17 new initiatives with strategic partners and 4 new investments in he
Philips' (PHG) Reports Positive AI-Powered Cardiac Study Data
02:21pm, Monday, 20'th May 2024
Philips' (PHG) AI-powered cardiac monitoring solutions demonstrate significantly lower re-admissions and a higher rate of survival in the retrospective study evaluating it in stroke patients.
Koninklijke Philips (NYSE:PHG) Shares Sold by National Bank of Canada FI
05:07am, Monday, 20'th May 2024
National Bank of Canada FI cut its position in Koninklijke Philips (NYSE:PHG – Free Report) by 89.8% during the 4th quarter, according to the company in its most recent filing with the Securitie
May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmission
Philips announces exchange ratio for 2023 dividend
05:00am, Wednesday, 15'th May 2024
May 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 exi
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
01:16pm, Tuesday, 14'th May 2024
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
